Schaffhausen, Switzerland, 20/02/26 - BioGaia AB (NASDAQ: BIOG) has signed a renewed distribution agreement with Ewopharma. The extended agreement reinforces the companies’ successful collaboration to date and reflects a shared ambition to further accelerate growth across the European region.
Under the new agreement, Ewopharma will distribute a broad range of BioGaia’s product portfolio in more than 15 European countries, strengthening the companies’ joint efforts to make BioGaia’s probiotic products more widely available to consumers.
“We are very pleased to continue this partnership with Ewopharma,” says Theresa Agnew, President and CEO of BioGaia. “Their deep knowledge of European markets, strong commercial capabilities, and well-established distribution network enable us to reach more consumers and healthcare professionals with our high-quality probiotic products. Ewopharma’s local expertise and commitment to our brand have been instrumental in driving our growth in Central Eastern Europe.”
“We are proud to extend our partnership with BioGaia,” says Alain Staub, President of the Board of Directors and CEO of Ewopharma. “This agreement underscores our mutual trust and shared vision for the region. We look forward to continuing to expand the reach of BioGaia’s innovative portfolio across our markets.”